InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,302.00
(
0.45%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.42
(
1.12%
)
Bitcoin
61,554.25
(
1.22%
)
Post# of 45771
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

capnmike

Send PM Follow Ignore
Followers 0
Posts 2715
Boards Moderated 0
Alias Born 08/04/2003

capnmike

Re: arloco post# 12285

Wednesday, 06/28/2006 7:12:15 AM

Wednesday, June 28, 2006 7:12:15 AM

Post# of 45771
Arloco, it is interesting...

My opinion too...

A new generation... different sample requirements... probably integrates a new generation of signatures. CDEX and Baxa both appear to be very busy, with results that look good to me.


The next-generation ValiMed Technology offers the same benefits as the original system, with additional reporting features and a smaller sample requirement.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-26-2006/0004386956&....

New ValiMed(TM) Medication Validation System DemonstratesUSP < 797 > Compliance at ASHP Summer Meeting

Baxa Corporation demonstrates the next-generation ValiMed System



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up